Skip to main content
Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0251
+0.0001 (0.40%)
Jun 6, 2025, 1:58 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Gene Control Medicines
9.94M
Log In
Log In
Log In
Log In
Upgrade
Gene Control Medicines Growth
-33.23%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
9.94M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-33.23%
Log In
Log In
Log In
Log In
Upgrade